Y2T-24356-09789
3 vaccinations
6 coded responses
32 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 076 / NJ
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-03
Registered in v-safe
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-04
- 2021-04-06
- 2021-04-07
- 2021-04-09
- 2021-04-16
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-26
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
-
2021-07-25
Survey response — 3 months, dose 2MedDRA: Balance disorder, Fatigue, Headache, Muscle spasms, Muscular weakness, Office visit, Tremor — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Very low grade headaches. Feeling unsteady/off balance. Right side weakness in arm/hand with tremors. Extreme fatigue. Muscle spasms in neck, into part of face. · Healthcare visit (other): Saw my primary doctor, sent for MRIs. Going to Neurologist next week.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-25
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-03
-
2021-10-23
Survey response — 6 months, dose 2MedDRA: Balance disorder, Central nervous system lesion, Dizziness, Headache, Magnetic resonance imaging head abnormal, Muscle spasms, Office visit, Tremor — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I have brain lesions found on MRI. Constant dizziness, off balance. Tremors into hands. Spasms. Headaches. · Healthcare visit (other): Primary Doctor, NeurologistMedDRA releases: 2024-11 · check-in free text available
-
2021-10-23
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-27
-
2021-12-09
Dose 3 — Pfizer-BioNTech
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-12-11
Survey response — days 1–6 daily, dose 3MedDRA: Injection site bruising — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Bruise at injection site.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-23
- 2021-12-30
- 2022-01-06
- 2022-01-13
- 2022-01-20
-
2022-03-12
Survey response — 3 months, dose 3MedDRA: Visual field defect — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Peripheral vision in right eye is going dark, like a shadow or shade blocking sight.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-09
Survey response — 6 months, dose 3MedDRA: Multiple sclerosis, Office visit, Optic neuritis, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Symptoms: I've recently been diagnosed with MS and optic neuritis. · Healthcare visit (other): In office visits.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-09
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-06-10
- 2022-06-10
- 2022-06-10
-
2022-12-09
Survey response — 12 months, dose 3MedDRA: Multiple sclerosis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I've been diagnosed with MS (rrms).MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-25 | Unsuccessful | |
| 2021-10-23 | Unsuccessful | |
| 2022-06-09 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: Very low grade headaches. Feeling unsteady/off balance. Right side weakness in arm/hand with tremors. Extreme fatigue. Muscle spasms in neck, into part of face.
Healthcare visit (other): Saw my primary doctor, sent for MRIs. Going to Neurologist next week.
Release 10 — 6 months, dose 2
Symptoms: I have brain lesions found on MRI. Constant dizziness, off balance. Tremors into hands. Spasms. Headaches.
Healthcare visit (other): Primary Doctor, Neurologist
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Bruise at injection site.
Release 11 — 3 months, dose 3
Symptoms: Peripheral vision in right eye is going dark, like a shadow or shade blocking sight.
Release 12 — 6 months, dose 3
Symptoms: I've recently been diagnosed with MS and optic neuritis.
Healthcare visit (other): In office visits.
Release 12 — 12 months, dose 3
Symptoms: I've been diagnosed with MS (rrms).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Balance disorder | ✓ | · | ✓ |
| SD | Central nervous system lesion | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Magnetic resonance imaging head abnormal | · | · | ✓ |
| SD | Multiple sclerosis | · | · | ✓ |
| SD | Muscle spasms | ✓ | · | ✓ |
| SD | Muscular weakness | ✓ | · | ✓ |
| SD | Optic neuritis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Tremor | ✓ | · | ✓ |
| SD | Visual field defect | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release